[1]
O’Reilly, D.J. et al. 2018. THE UNINTENDED (AND COSTLY) EFFECTS DUE TO THE INTRODUCTION OF AN UNRESTRICTED REIMBURSEMENT POLICY FOR ATYPICAL ANTIPSYCHOTIC MEDICATIONS IN A CANADIAN PUBLIC PRESCRIPTION DRUG PROGRAM: 1996/97 TO 2005/06. Journal of Population Therapeutics and Clinical Pharmacology. 16, 2 (Dec. 2018).